A detailed history of Royal Bank Of Canada transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Royal Bank Of Canada holds 600 shares of SOPH stock, worth $1,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600
Previous 615 2.44%
Holding current value
$1,986
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.19 - $4.8 $47 - $72
-15 Reduced 2.44%
600 $2,000
Q2 2024

Aug 14, 2024

BUY
$4.46 - $5.55 $66 - $83
15 Added 2.5%
615 $2,000
Q1 2024

Nov 05, 2024

SELL
$4.21 - $5.62 $63 - $84
-15 Reduced 2.44%
600 $2,000
Q4 2023

Feb 14, 2024

BUY
$2.5 - $4.87 $1,500 - $2,922
600 New
600 $2,000

Others Institutions Holding SOPH

About SOPHiA GENETICS SA


  • Ticker SOPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 64,153,700
  • Market Cap $212M
  • Description
  • SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...
More about SOPH
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.